benefits of glp-1 therapy is often talked about for weight loss — but its go far beyond the scale. It helps regulate appetite, insulin sensitivity, digestion, heart health, and how your brain responds ✨ GLP-1 medications do more

Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat

Mice were maintained on a standard diet, and water was freely available

Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior weight loss and expanded therapeutic applications spanning from brain health to renal disease". Lillys Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade Davy James Key Takeaways Eli Lilly's orforglipron and retatrutide are pivotal in the cardiometabolic market, with significant sales projections by 2031

[Crossref] Malaguarnera M, Pistone G, Elvira R, Leotta C, Scarpello L, et al